8i Acquisition 2 Corp. (LAX): history, ownership, mission, how it works & makes money

Born in January 2021 as a British Virgin Islands SPAC with a clear Asia-tech mandate, 8i Acquisition 2 Corp. vaulted to market in November 2021 by raising $86.25 million through the sale of 8,625,000 units at $10 apiece and pivoted in 2022 into healthcare by combining with Singapore-based EUDA Health to form EUDA Health Holdings Limited, a digital health platform led by CEO and Chairman James Meng Dong Tan (the largest individual holder at roughly 22%), while today the stock trades at $2.26 per share (as of December 16, 2025); backed by a shareholder base where 54% is institutional, the company operates a unified AI-driven platform delivering e-triage, GP consults, telehealth, urgent care and medical evacuation, property management and end-to-end post-surgical and preventive care across Singapore, Malaysia, Vietnam, India and Indonesia, monetizing through service fees, urgent-care contracts and property management revenues, and projecting an aggressive growth profile with estimated 2023 revenue and adjusted EBITDA of $200 million and $43 million, respectively-details that set the stage for a closer look at history, ownership, mission, operations and the diversified monetization strategy that underpin EUDA's push to make healthcare more affordable and accessible across Southeast Asia.

8i Acquisition 2 Corp. (LAX) - Intro

• Incorporated January 2021 in the British Virgin Islands to target high‑growth technology companies in Asia.
• Completed IPO November 2021, raising $86.25 million by offering 8,625,000 units at $10.00 per unit (each unit: one ordinary share, one warrant, one right).
• Announced business combination April 2022 with EUDA Health Limited, a Singapore‑based digital health platform.
• Shareholders approved the combination in November 2022; the merged entity operates as EUDA Health Holdings Limited with Dr. Kelvin Chen as CEO.
• As of December 16, 2025, the company's common stock is trading at $2.26 per share.

• Initial public float: 8,625,000 ordinary shares issued as part of units at IPO.
• Public warrants and rights issued with units (exercisable according to warrant/right terms set at IPO).
• Post‑combination ownership includes LAX public shareholders, EUDA Health stockholders rolling equity, and new/regulatory shareholders introduced via the merger - exact post‑merger share count varies with warrant conversions and any additional financing rounds.

• Mission: Bring high‑quality, scalable Asian tech and digital health businesses to public markets, accelerating growth through access to capital and global markets.
• Strategic focus areas: digital health platforms, technology solutions with scalable unit economics, and Asian markets with cross‑border expansion potential.
• Reference: Mission Statement, Vision, & Core Values (2026) of 8i Acquisition 2 Corp.

• SPAC formation: Raise capital via IPO of units, hold funds in trust while sourcing a target business (typically 24 months).
• Target selection: Focus on technology companies in Asia with strong growth profiles and strategic fit for public markets.
• Business combination: Negotiate merger terms (share exchange, equity rollovers, PIPEs), obtain shareholder approval, and consummate the transaction to form the public operating company.
• Post‑combination: Operate as the combined public company (EUDA Health Holdings Limited), led by management of the target (CEO Dr. Kelvin Chen), leveraging IPO proceeds and any additional financing to scale operations.

• Pre‑combination: SPAC generates nominal revenue (sponsor fees, interest on trust cash) - primary value creation is through deal sourcing and structuring.
• Post‑combination (EUDA Health): Revenue derived from digital health services, platform subscriptions, B2B partnerships, telemedicine fees, and possible device/software integrations depending on EUDA's product mix.
• Value drivers: user growth and engagement, monetization of platform services, successful integration and expansion in Asia, margin expansion, and execution on growth initiatives funded by IPO and potential PIPE capital.

8i Acquisition 2 Corp. (LAX): History

• IPO and trust capital raise (initial cash per public share placed in trust)
• Sponsor and insider investment rounds to cover transaction expenses
• Target search, LOI/definitive agreement phases and shareholder votes

• Largest individual shareholder: CEO & Chairman James Meng Dong Tan - ~22% ownership.
• Institutional concentration (~54%) drives liquidity and vote outcomes for any business combination.

• To identify and combine with a high-growth company where public-market access and capital can accelerate expansion.
• Focus on creating shareholder value via the combination, operational support and public-market governance.

8i Acquisition 2 Corp. (LAX): Ownership Structure

• Mission alignment: EUDA Health Holdings Limited's mission is to make healthcare more affordable and accessible while improving the patient experience and outcomes through personalized healthcare and advanced analytics.
• Strategic focus: the target profile sought by LAX typically includes businesses offering integrated medical, wellness and virtual/community clinic services, non‑invasive treatments, and data‑driven care delivery.
• Value creation: LAX aims to assemble scale, bring operational expertise, and deploy capital to expand end‑to‑end care ecosystems and accelerate technology integration for holistic healthcare access.

• How the ownership converts on a business combination: public shareholders can redeem trust shares for cash; sponsor equity is usually rolled into pro forma equity to maintain founder incentives.
• Revenue model post‑combination: the merged company (e.g., EUDA Health) monetizes via clinical services, subscription/virtual care fees, allied‑care programs, and platform analytics/licensing.
• Performance alignment: sponsor and management typically retain equity upside to align with long‑term operational targets like patient throughput, margin expansion, and recurring revenue growth.

8i Acquisition 2 Corp. (LAX): Mission and Values

• AI-driven intake and e-triage: automated assessment of symptoms and medical history to prioritize cases and route to appropriate clinicians.
• Digital clinician connection: video/telehealth GP consults, e-prescriptions, and issuance of e-medical certificates within the platform.
• Care continuum support: from wellness/prevention to urgent care, emergency response and post-surgical follow-up.
• On-demand medical evacuation and urgent response for individual and corporate clients.
• Property management integration: management of commercial and residential assets (e.g., condominiums, shopping centers) to create integrated client ecosystems and recurring revenue.

• Rapid assessment: average AI triage time under 90 seconds (platform target) to determine acuity and next steps.
• Seamless escalation: e-triage → GP consult → prescriptions or urgent referral (including medical evacuation where required).
• Longitudinal care: scheduling and follow-up workflows for preventive care and chronic-condition monitoring.
• Data-driven outcomes: predictive models estimate optimal treatment paths and projected recovery timelines.

• Subscription/ARR: recurring platform subscriptions for employers and insurers - pricing tiers per employee per month (PEPM) or per-member-per-month (PMPM).
• Fee-for-service: per-visit telemedicine and urgent care fees, e-prescription charges, and evacuation incident fees.
• Managed services: property management contracts with fixed monthly management fees plus performance-based revenue (e.g., tenant retention incentives).
• Ancillary revenue: diagnostic partner fees, pharmacy fulfillment margins, and value-based care shared savings.

• Customer Acquisition Cost (CAC): varies by channel; employer-channel CAC amortized over multi-year contracts to improve payback period.
• Lifetime Value (LTV): derived from PMPM, retention rates, and upsell into urgent care and evacuation services; target LTV:CAC > 3x.
• Utilization Rates: telemedicine utilization targets of 10-25% of covered members per year to drive engagement.
• Average Case Cost Avoidance: platform aims to divert costly ED visits-projected per-visit savings of $300-$1,200 vs. emergency care.

• Technology: API-first architecture for EMR/EHR integration, billing systems and third-party provider networks.
• Clinical Network: contracting with licensed GPs, specialists, and medevac partners to cover geographies and levels of acuity.
• Compliance: HIPAA/GDPR-aligned data handling, clinical governance and quality metrics reporting for payors and employers.
• Go-to-market: sales through broker channels, benefits consultants, and direct enterprise partnerships.

8i Acquisition 2 Corp. (LAX): How It Works

• Origin: 8i Acquisition 2 Corp. (LAX) launched as a special purpose acquisition company (SPAC) to identify and merge with high-growth targets in health-tech and Southeast Asia-focused healthcare services.
• Ownership: Post-business combination, the ownership mix typically includes former SPAC sponsor shares, PIPE investors, public shareholders, and rollover equity from target company founders and management.
• Mission: To scale an integrated, tech-enabled healthcare platform across Southeast Asia by combining telehealth, urgent care, medical logistics and property-management-enabled service sites to expand access and create recurring revenue.

• Platform structure: The combined entity operates an AI-driven telehealth platform, urgent care/medical evacuation services, property-anchored service hubs (e.g., clinics in condos and malls), and a continuum-of-care offering from e-triage to post-surgery follow-up.
• Customer flows:
  • Direct-to-consumer telehealth users access e-triage, GP consults, e-medical certificates and prescriptions via app/web.
  • Corporate clients contract urgent care, on-site medical coverage and medical evacuation services for employees and insured populations.
  • Property management partnerships provide built-in foot traffic and leasing revenue while hosting clinical operations.
• Technology and delivery:
  • AI triage routes cases to self-care guidance, remote GP consults, or escalation to urgent care/evacuation.
  • Integrated EMR and pharmacy fulfillment enable prescription monetization and continuum care tracking.

• Telehealth fees: Per-consultation fees (video/chat), subscription plans for repeat users, and value-added AI triage services charged to patients or payors.
• Urgent care & medical evacuation: Fee-for-service urgent care visits, standby/corporate contracts, and premium charges for medical transport and evacuation services.
• Property management income: Management fees, facility leasing and revenue share from retail/clinic tenants in condominiums and malls.
• Clinical services & prescriptions: Revenue from e-medical certificates, e-prescriptions, diagnostics, and post-op follow-ups; pharmacy margins and referral fees augment margins.
• Enterprise contracts and B2B: Corporate healthcare programs, insurance partnerships and employer-paid care packages that provide predictable recurring revenue.

• Geographic expansion across Southeast Asian markets to tap underserved populations and increase MAU.
• Enhancing service depth - adding post-surgery care, chronic disease management and pharmacy fulfillment to raise ARPU and retention.
• Scaling enterprise contracts (employers & insurers) to convert one-off fees into recurring, contracted revenue.
• Property-led expansion to create low-cost, owned/managed physical touchpoints that drive cross-sell to digital services.

8i Acquisition 2 Corp. (LAX): How It Makes Money

• Geographic footprint: Singapore, Malaysia, Vietnam, India, Indonesia (expanded to these markets by end of 2022).
• Primary revenue streams: subscription fees for digital clinic access, fee-for-service telemedicine visits, pharmacy fulfillment margin, chronic-care management contracts, and B2B enterprise solutions.
• Strategic partners: alliances with internationally recognized blue-chip organizations to accelerate customer acquisition and enterprise contracts.
• Value focus: sustainable growth targeting shareholders, patients, and partners via scalable unit economics and integrated care delivery.

• Scale of telehealth visits and subscription uptake improves gross margins via fixed-cost dilution.
• Vertical integration with pharmacy and diagnostics increases per-patient revenue and retention.
• Enterprise contracts (capitated or outcome-based) stabilize long-term recurring revenue and EBITDA visibility.
• Cross-border expansion leverages shared technology stack to reduce incremental customer acquisition cost (CAC).